These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1591056)

  • 1. Long-term prognostic significance of thymidine labelling index in primary breast cancer.
    Cooke TG; Stanton PD; Winstanley J; Murray GD; Croton R; Holt S; George WD
    Eur J Cancer; 1992; 28(2-3):424-6. PubMed ID: 1591056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term prognostic significance of the thymidine labelling index in breast cancer.
    Tubiana M; Pejovic MH; Chavaudra N; Contesso G; Malaise EP
    Int J Cancer; 1984 Apr; 33(4):441-5. PubMed ID: 6706431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index.
    Silvestrini R; Daidone MG; Luisi A; Mastore M; Leutner M; Salvadori B
    Int J Cancer; 1997 Feb; 74(1):122-7. PubMed ID: 9036880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro thymidine labelling index in primary operable breast cancer.
    Holt S; Croton R; Leinster SJ; McDicken I; Nicholson RI; Cooke TG; George WD
    Eur J Surg Oncol; 1986 Mar; 12(1):53-7. PubMed ID: 3956755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine labeling index: prognostic role in breast cancer.
    Bilir A; Ozmen V; Kecer M; Eralp Y; Cabioglu N; Ahishali B; Camlica H; Aydiner A
    Am J Clin Oncol; 2004 Aug; 27(4):400-6. PubMed ID: 15289735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive value of thymidine labelling index in breast cancer.
    Amadori D; Silvestrini R
    Breast Cancer Res Treat; 1998; 51(3):267-81. PubMed ID: 10068084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the Tritiated Thymidine Labeling Index in breast cancers.
    Araki K; Kimura M; Sakamoto K; Nishimura R; Akagi M
    Jpn J Surg; 1985 Mar; 15(2):144-9. PubMed ID: 4010096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The errors of thymidine labelling in breast cancer.
    Smallwood JA; Cooper A; Taylor I
    Clin Oncol; 1983 Dec; 9(4):331-5. PubMed ID: 6661855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up.
    Bult P; Manders P; Straatman HM; Tjan-Heijnen VC; Beex LV; Hendriks J; Leer JW; Verbeek AL; Holland R
    Breast Cancer Res Treat; 2010 Jul; 122(1):77-86. PubMed ID: 19760038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations.
    Meyer JS; Coplin MD
    Am J Clin Pathol; 1988 May; 89(5):586-95. PubMed ID: 3358366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
    Lipponen P; Papinaho S; Eskelinen M; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
    Anticancer Res; 1992; 12(5):1533-8. PubMed ID: 1444217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast.
    Kamel OW; Franklin WA; Ringus JC; Meyer JS
    Am J Pathol; 1989 Jan; 134(1):107-13. PubMed ID: 2536520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma.
    Frkovic-Grazio S; Bracko M
    J Clin Pathol; 2002 Feb; 55(2):88-92. PubMed ID: 11865000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3H-thymidine labelling index (TLI) as a marker of tumour growth heterogeneity: evaluation in human solid carcinomas.
    Becciolini A; Balzi M; Barbarisi M; Faraoni P; Biggeri A; Potten CS
    Cell Prolif; 1997; 30(3-4):117-26. PubMed ID: 9375024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.
    Baak JP; Colpaert CG; van Diest PJ; Janssen E; van Diermen B; Albernaz E; Vermeulen PB; Van Marck EA
    Eur J Cancer; 2005 Sep; 41(14):2093-101. PubMed ID: 16153819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidine labeling index in epithelial ovarian cancer.
    Salihoglu Y; Bilir A; Aydiner A; Erkan M; Tuzlali S; Eralp Y
    Int J Gynaecol Obstet; 2001 Nov; 75(2):171-6. PubMed ID: 11684112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of thymidine kinase in cancer of the breast].
    Romain S; Javre JL; Samperez S; Jouan P; Bressac C; Varette I; Brandone H; Martin PM
    Bull Cancer; 1990; 77(10):973-83. PubMed ID: 2249017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro DNA synthesis in freshly separated human breast cancer cells assessed by tritiated thymidine incorporation assay: relationship to the long-term outcome of patients.
    Nio Y; Tamura K; Kan N; Inamoto T; Ohgaki K; Kodama H
    Br J Surg; 1999 Nov; 86(11):1463-9. PubMed ID: 10583297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy.
    Meyer JS; Wittliff JL
    Int J Cancer; 1991 Jan; 47(2):213-20. PubMed ID: 1988366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma.
    Alama A; Merlo F; Chiara S; Muttini MP; Guido T; Nicolò G; Conte PF; Ragni N
    Eur J Cancer; 1992; 28A(6-7):1079-80. PubMed ID: 1627379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.